Athanasios Skarpelos
CIK: 0001360570
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVXL
ANAVEX LIFE SCIENCES CORP.
Director
Discretionary Trading P&L
Holdings
About Skarpelos Athanasios
Skarpelos Athanasios (SEC CIK 0001360570) files insider reports with the SEC as Director of ANAVEX LIFE SCIENCES CORP. (AVXL).
Signal8 holds 1 ownership filing by Skarpelos Athanasios, a Form 4, filed on Apr 2, 2025. Those filings report 1 transaction, the latest on Mar 31, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Skarpelos Athanasios's filings is in NEW YORK, NY.
Recent filings by Skarpelos Athanasios
- Mar 31, 2025: Grant or award of AVXL derivative securities (Form 4, code A).
Other insiders filing for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Senderowicz Adrian, Director
- Patel Gautam, Director
- Boenisch Sandra, PFO & Treasurer
- Kellmeyer Terrie, Interim CEO
- Paeger Axel, Director
- MISSLING CHRISTOPHER U, President and CEO